Bristol-Myers Squibb Co. saw a 1.90% share price increase on Friday due to positive news on its cancer treatment Opdivo. Despite market downturn, 10 firms ended strong, with BMY ranking 9th.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing